The tripeptide NGR (Asn‐Gly‐Arg) was notably competent for anchoring tumor‐related angiogenic vessels, molecularly targeting aminopeptidase N (ANPEP/CD13) in endothelial cells.279. Here, RTN4R is linked to neoplasm.